International Journal of Clinical Case Reports 2024, Vol.14, No.3, 164-174 http://medscipublisher.com/index.php/ijccr 172 Agostinetto E., Montemurro F., Puglisi F., Criscitiello C., Bianchini G., Mastro L., Introna M., Tondini C., Santoro A., and Zambelli A., 2022, Immunotherapy for HER2-positive breast cancer: clinical evidence and future perspectives, Cancers, 14(9): 2136. https://doi.org/10.3390/cancers14092136 PMid:35565264 PMCid:PMC9105460 Alard E., Butnariu A., Grillo M., Kirkham C., Zinovkin D., Newnham L., Macciochi J., and Pranjol M., 2020, Advances in anti-cancer immunotherapy: car-T cell, checkpoint inhibitors, dendritic cell vaccines, and oncolytic viruses, and emerging cellular and molecular targets, Cancers, 12(7): 1826. https://doi.org/10.3390/cancers12071826 PMid:32645977 PMCid:PMC7408985 Bagchi S., Yuan R., and Engleman E., 2020, Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance, Annual review of pathology, 16: 223-249. https://doi.org/10.1146/annurev-pathol-042020-042741 PMid:33197221 Bai R., Chen N., Li L., Du N., Bai L., Lv Z., Tian H., and Cui J., 2020, Mechanisms of cancer resistance to immunotherapy, Frontiers in Oncology, 10: 1290. https://doi.org/10.3389/fonc.2020.01290 PMid:32850400 PMCid:PMC7425302 Barzaman K., Moradi-Kalbolandi S., Hosseinzadeh A., Kazemi M., Khorramdelazad H., Safari E., and Farahmand L., 2021, Breast cancer immunotherapy: current and novel approaches, International Immunopharmacology, 98: 107886. https://doi.org/10.1016/j.intimp.2021.107886 PMid:34153663 Basu A., Ramamoorthi G., Jia Y., Faughn J., Wiener D., Awshah S., Kodumudi K., and Czerniecki B., 2019, Immunotherapy in breast cancer: current status and future directions, Advances in Cancer Research, 143: 295-349. https://doi.org/10.1016/bs.acr.2019.03.006 PMid:31202361 Bou-Dargham M., Draughon S., Cantrell V., Khamis Z., and Sang Q., 2021, Advancements in human breast cancer targeted therapy and immunotherapy, Journal of Cancer, 12: 6949-6963. https://doi.org/10.7150/jca.64205 PMid:34729098 PMCid:PMC8558657 Bou-Dargham M., Liu Y., Sang Q., and Zhang J., 2018, Abstract P3-05-18: the complex landscape of breast cancer immune evasion and its implications to personalized and combined immunotherapy, Cancer Research, 78 (4_Supplement): P3-05-18. https://doi.org/10.1158/1538-7445.SABCS17-P3-05-18 Darvin P., Toor S., Nair V., and Elkord E., 2018, Immune checkpoint inhibitors: recent progress and potential biomarkers, Experimental and Molecular Medicine, 50(12): 1-11. https://doi.org/10.1038/s12276-018-0191-1 PMid:30546008 PMCid:PMC6292890 Elsas M., Hall T., and Burg S., 2020, Future challenges in cancer resistance to immunotherapy, Cancers, 12(4): 935. https://doi.org/10.3390/cancers12040935 PMid:32290124 PMCid:PMC7226490 Ende N., Nguyen A., Jager A., Kok M., Debets R., and Deurzen C., 2023, Triple-negative breast cancer and predictive markers of response to neoadjuvant chemotherapy: a systematic review, International Journal of Molecular Sciences, 24(3): 2969. https://doi.org/10.3390/ijms24032969 PMid:36769287 PMCid:PMC9918290 Esteva F., Hubbard-Lucey V., Tang J., and Pusztai L., 2019, Immunotherapy and targeted therapy combinations in metastatic breast cancer, The Lancet, Oncology, 20(3): e175-e186. https://doi.org/10.1016/S1470-2045(19)30026-9 PMid:30842061 Gajewski T., 2015, The next hurdle in cancer immunotherapy: overcoming the non-t-cell-inflamed tumor microenvironment, Seminars in Oncology, 42(4): 663-671. https://doi.org/10.1053/j.seminoncol.2015.05.011 PMid:26320069 PMCid:PMC4555998 García-Aranda M., and Redondo M., 2019, Immunotherapy: a challenge of breast cancer treatment, Cancers, 11(12): 1822. https://doi.org/10.3390/cancers11121822 PMid:31756919 PMCid:PMC6966503 Guerra L., Bonetti L., and Brenner D., 2020, Metabolic modulation of immunity: a new concept in cancer immunotherapy, Cell Reports, 32(1): 107848. https://doi.org/10.1016/j.celrep.2020.107848 PMid:32640218 Hanna A., and Balko J., 2021, Breast cancer resistance mechanisms: challenges to immunotherapy, Breast Cancer Research and Treatment, 190(1): 5-17. https://doi.org/10.1007/s10549-021-06337-x PMid:34322780 PMCid:PMC8560575
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==